Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingphase_3

Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)

NCT07028827
recruitingnot_applicable

Early-Onset Myopia Intervention Project

NCT07176949
recruitingnot_applicable

A-eyedrops on Ocular Alignment and Binocular Vision

NCT05379855

Clinical Trials (3)

Showing 3 of 3 trials
NCT07028827Phase 3

Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)

Recruiting
NCT07176949Not Applicable

Early-Onset Myopia Intervention Project

Recruiting
NCT05379855Not Applicable

A-eyedrops on Ocular Alignment and Binocular Vision

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3